Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (2): 196-199.DOI: 10.3969/j.issn.1673-8640.2023.02.019
Previous Articles Next Articles
Received:2021-12-02
Revised:2022-04-28
Online:2023-02-28
Published:2023-04-17
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.02.019
| [1] | 刘艳荣. 实用流式细胞术[M]. 北京: 北京大学医学出版社, 2010. |
| [2] | 医政医管局《关于印发儿童急性淋巴细胞白血病、儿童急性早幼粒细胞白血病诊疗规范(2018年版)的通知》[EB/OL]. (2018-10-16)[2021-12-01]. http://www.nhc.gov.cn/yzygj/s7653/201810/aef82930c1af4fc5bf325938e2fcb075.shtml. |
| [3] |
OHKI K, KIYOKAWA N, SAITO Y, et al. Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood,including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion[J]. Haematologica, 2019, 104(1):128-137.
DOI URL |
| [4] |
JASEB K, PURRAHMAN D, SHAHRABI S, et al. Prognostic significance of aberrant CD5 expression in B-cell leukemia[J]. Oncol Rev, 2019, 13(1):400.
DOI PMID |
| [5] |
STALEY E M, FELDMAN A Z, KOENIG R G, et al. CD5 positive B-ALL,a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature[J]. Pediatr Blood Cancer, 2019, 66(1):e27484.
DOI URL |
| [6] | SREEDHARANUNNI S, KUMAR N, KHADWAL A. CD5 positive B lymphoblastic leukemia:report of a case with review of literature[J]. Indian J Hematol Blood Transfus, 2016, 32(Suppl 1):1-4. |
| [7] |
YE M T, ZHU J, LUO D X, et al. B-lymphoblastic leukemia with aberrant CD5 expression[J]. Am J Clin Pathol, 2021, 156(4):586-595.
DOI PMID |
| [8] | SHAHNI A, SAUD M, SIDDIQUI S, et al. Expression of aberrant antigens in hematological malignancies:a single center experience[J]. Pak J Med Sci, 2018, 34(2):457-462. |
| [9] | BASTURK A, AKINCI S, HACIBEKIROGLU T, et al. Prognostic significance of flow cytometry findings in Turkish adult acute leukemia patients[J]. Eur Rev Med Pharmacol Sci, 2015, 19(18):3360-3366. |
| [10] |
DANNHEIM K C, POZDNYAKOVA O, DAL CIN P, et al. Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and TP53 mutations[J]. J Clin Pathol, 2018, 71(12):1051-1059.
DOI URL |
| [11] | 王维维, 邱丽君, 章黎华, 等. 儿童ETP-ALL 1例报道及ETP-ALL诊断标准分析[J]. 检验医学, 2021, 36(11):1194-1197. |
| [12] | GAO Y, FENG X Q, LIU S S, et al. Acute myeloid leukemia with T lymphoblastic lymphoma:a case report and literature review[J]. J Int Med Res, 2021, 49(5):3000605211016138. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
